Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Protocol for isolating single species of bacteria with swarming ability from human feces
Publication Year: 2024 Source: STAR Protoc PMID: 38573864
No Abstract
Self-assembling peptide hydrogel scaffold integrating stem cell-derived exosomes for infected bone defects
Publication Year: 2024 Source: J Biomater Sci Polym Ed PMID: 38574263 DOI: 10.1080/09205063.2024.2336316
Infected bone defect (IBD) is a great challenge in orthopedics, which involves in bone loss and infection. Here, a self-assembling hydrogel scaffold (named AMP-RAD/EXO), integrating antimicrobial peptides(AMPs), RADA16 and BMSCs exosomes with an innovative strategy, is developed and applied in IBD treatment for sustained antimicrobial ability, accelerating osteoblasts proliferation and …
Industrial-produced lemon nanovesicles ameliorate experimental colitis-associated damages in rats via the activation of anti-inflammatory and antioxidant responses and microbiota modification
Publication Year: 2024 Source: Biomed Pharmacother PMID: 38574618 DOI: 10.1016/j.biopha.2024.116514
Plant-derived nanovesicles (PDNVs) have recently emerged as natural delivery systems of biofunctional compounds toward mammalian cells. Considering their already described composition, anti-inflammatory properties, stability, and low toxicity, PDNVs offer a promising path for developing new preventive strategies for several inflammatory diseases, among which the inflammatory bowel disease (IBD). In this …
Mitigation of inflammatory bowel disease-related osteoporosis by oxyberberine: Insights into the RANKL/NF-κB signaling pathway
Publication Year: 2024 Source: Biomed Pharmacother PMID: 38574627
No Abstract
TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
Publication Year: 2024 Source: Med PMID: 38574740 DOI: 10.1016/j.medj.2024.03.010
The pivotal role of TL1A in modulating immune pathways crucial for inflammatory bowel disease (IBD) and intestinal fibrosis offers a promising therapeutic target. Phase 2 trials (TUSCANY and ARTEMIS-UC) evaluating an anti-TL1A antibody show progress in expanding IBD therapeutic options. First-in-human data reveal reduced expression of genes associated with extracellular …
Cmtm4 deficiency exacerbates colitis by inducing gut dysbiosis and S100a8/9 expression
Publication Year: 2024 Source: J Genet Genomics PMID: 38575111
No Abstract
Associations of Eosinophilic Gastrointestinal Disorders with Other Gastrointestinal and Allergic Diseases
Publication Year: 2024 Source: Immunol Allergy Clin North Am PMID: 38575227
No Abstract
Is the writing on the wall? The relationship between the number of disease-modifying anti-inflammatory bowel disease drugs used and the risk of surgical resection
Publication Year: 2024 Source: J Gastrointest Surg PMID: 38575464
No Abstract
Identification and surgical management of acute severe ulcerative colitis: A guide for general practitioners
Publication Year: 2024 Source: Aust J Gen Pract PMID: 38575541
No Abstract
Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8(+) T cells in murine models of inflammation
Publication Year: 2024 Source: Nat Commun PMID: 38575593
No Abstract
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide